Our commitment to quality ensures healthcare providers receive reliable tools for critical patient care and drug preparation
[DOI] [PubMed] [Google Scholar] 7.Ale F, Alves RC, Arajo JF, Azevedo A, Bacelar A, Bezerra M, et al
Continuous daily use is not recommended, particularly for those with a cancer history
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry